Stockscreener 앱 받기
1.26
3.82%
-0.05
시간 외 거래:
1.27
0.01
+0.79%
전일 마감가:
$1.31
열려 있는:
$1.32
하루 거래량:
3.58M
Relative Volume:
1.03
시가총액:
$226.47M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-1.1776
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
-13.70%
1개월 성능:
-6.67%
6개월 성능:
-75.86%
1년 성능:
-71.43%
1일 변동 폭
$1.25
$1.33
1주일 범위
$1.25
$1.48
52주 변동 폭
$1.15
$9.97
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.26 | 226.47M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA ViolationsHagens Berman - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) Shareholders - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Humacyte, Inc.(HUMA) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Shareholders that lost money on Humacyte, Inc.(HUMA) should contact Levi & Korsinsky about pending Class ActionHUMA - ACCESS Newswire
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - MSN
Humacyte Insiders Placed Bullish Bets Worth US$949.4k - Yahoo Finance
All You Need to Know About Humacyte, Inc. (HUMA) Rating Upgrade to Buy - Yahoo Finance
Humacyte, Inc. (HUMA) Stock Moves -0.68%: What You Should Know - MSN
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - MSN
Shareholders that lost money on Humacyte, Inc. (HUMA) should contact Levi & Korsinsky about pending Class ActionHUMA - ACCESS Newswire
Shareholders that lost money on Humacyte, Inc.(HUMA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Humacyte, Inc. (NASDAQ:HUMA): Is Breakeven Near? - simplywall.st
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):